Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations

Clinical article

Restricted access

Object

Brain metastases are the most frequently occurring cerebral tumors. Tumors that are located in eloquent cerebral parenchyma can cause considerable morbidity and may pose a significant challenge during surgery. Gamma Knife surgery (GKS) is a recognized treatment modality for brain metastases. This study was undertaken to assess the safety and efficacy of GKS, specifically for brain metastases in eloquent locations.

Methods

Charts of patients harboring brain metastases that were treated by GKS at the Centre Hospitalier Universitaire de Sherbrooke between August 2004 and April 2008 were reviewed. Planning images were assessed by an independent neurosurgeon to assess tumor location. Eloquent locations included the primary motor, somatosensory, speech, and visual cortices; the basal ganglia; the thalamus; and the brainstem. Data on survival, tumor response, and complications were analyzed and compared with data published on surgical treatment of these lesions.

Results

During the study period, 650 metastases in 295 patients were treated with GKS; of these, 164 metastases in 95 patients were located in eloquent areas. In this subgroup, the median age of patients was 59 years and women constituted 57.9% of the population. The median Karnofsky Performance Scale score was 80% (range 50%–100%). Patients were categorized according to their recursive partitioning analysis class: Class 1, 22.1%; Class 2, 70.5%; and Class 3, 7.4% of patients. Non–small cell lung cancer was the most common primary tumor (63.2% of metastases), followed by small cell lung (8.4%), breast (7.4%), colorectal (5.3%), and renal cell (4.2%) cancers, as well as melanoma (4.2%). The median dose to the tumor margin was 18 Gy (range 14–24 Gy). The median duration of survival after GKS was 8.2 months. The recursive partitioning analysis class was the most significant variable affecting survival (p < 0.0001). Immediate control was achieved in 92.9% of tumors, and 68.6% of tumors were still controlled at the last follow-up. The median time to tumor progression was 16 months. Higher margin dose (p = 0.002), the absence of edema (p = 0.009), and the non–small cell lung cancer tissue type (p = 0.035) positively affected response rates. Steroid medications were no longer used in 46% of patients after GKS. New neurological deficits occurred in 5.7% of patients and seizures in 5.7%. All these deficits were transient and patients completely recovered in response to a temporary course of steroids. Imaging studies showed that new edema occurred in 8.6% of treated metastases and biopsy-proven radiation necrosis in 1.4%.

Conclusions

Gamma Knife surgery is safe and effective for brain metastases located in eloquent areas.

Abbreviations used in this paper: GKS = Gamma Knife surgery; KPS = Karnofsky Performance Scale; NSCLC = non–small cell lung cancer; RPA = recursive partitioning analysis; WBRT = whole-brain radiation treatment.

Article Information

Address correspondence to: David Mathieu, M.D., F.R.C.S.C., Service de Neurochirurgie, Centre Hospitalier Universitaire de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, Quebec, Canada J1H 5N4. email: david.mathieu@usherbrooke.ca.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Kaplan-Meier curve depicting overall survival after radiosurgery. Vertical lines indicate patient deaths.

  • View in gallery

    Kaplan-Meier curves of survival after radiosurgery according to RPA classification. Vertical lines show time of a censored observation (censuré).

  • View in gallery

    Kaplan-Meier depicting local control after radiosurgery. Vertical lines indicate tumor progression.

References

  • 1

    Al-Shamy GSawaya R: Management of brain metastases: the indispensable role of surgery. J Neurooncol 92:2752822009

  • 2

    Aoyama HShirato HTago MNakagawa KToyoda THatano K: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:248324912006

  • 3

    Black PMJohnson MD: Surgical resection for patients with solid brain metastases: current status. J Neurooncol 69:1191242004

  • 4

    Chen JCBugoci DMGirvigian MRMiller MJArellano ARahimian J: Control of brain metastases using frameless image-guided radiosurgery. Neurosurg Focus 27:6E62009

  • 5

    DeAngelis LMMandell LRThaler HTKimmel DWGalicich JHFuks Z: The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24:7988051989

  • 6

    Flickinger JCLunsford LDSomaza SKondziolka D: Radiosurgery: its role in brain metastasis management. Neurosurg Clin N Am 7:4975041996

  • 7

    Gaspar LScott CRotman MAsbell SPhillips TWasserman T: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:7457511997

  • 8

    Gaspar LEScott CMurray KCurran W: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:100110062000

  • 9

    Gavrilovic ITPosner JB: Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5142005

  • 10

    Gerosa MNicolato AForoni R: The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Curr Opin Oncol 15:1881962003

  • 11

    Gerosa MNicolato AForoni RZanotti BTomazzoli LMiscusi M: Gamma knife radiosurgery for brain metastases: a primary therapeutic option. J Neurosurg 97:5 Suppl5155242002

  • 12

    Macdonald DRCascino TLSchold SC JrCairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:127712801990

  • 13

    Mathieu DKondziolka DFlickinger JCFortin DKenny BMichaud K: Tumor bed radiosurgery after resection of cerebral metastases. Neurosurgery 62:8178242008

  • 14

    Mintz AHKestle JRathbone MPGaspar LHugenholtz HFisher B: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78:147014761996

  • 15

    Muacevic AKreth FWHorstmann GASchmid-Elsaesser RWowra BSteiger HJ: Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 91:35431999

  • 16

    Muacevic AWowra BSiefert ATonn JCSteiger HJKreth FW: Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:2993072008

  • 17

    Paek SHAudu PBSperling MRCho JAndrews DW: Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 56:102110342005

  • 18

    Patchell RATibbs PARegine WFDempsey RJMohiuddin MKryscio RJ: Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:148514891998

  • 19

    Patchell RATibbs PAWalsh JWDempsey RJMaruyama YKryscio RJ: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:4945001990

  • 20

    Sawaya R: Surgical treatment of brain metastases. Clin Neurosurg 45:41471999

  • 21

    Sneed PKSuh JHGoetsch SJSanghavi SNChappell RBuatti JM: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:5195262002

  • 22

    Soffietti RRudā RMutani R: Management of brain metastases. J Neurol 249:135713692002

  • 23

    Weil RJLonser RR: Selective excision of metastatic brain tumors originating in the motor cortex with preservation of function. J Clin Oncol 23:120912172005

  • 24

    Williams BJSuki DFox BDPelloski CEMaldaun MVSawaya RE: Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. Clinical article. J Neurosurg 111:4394482009

  • 25

    Yen CPSheehan JPatterson GSteiner L: Gamma knife surgery for metastatic brainstem tumors. J Neurosurg 105:2132192006

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 146 146 14
Full Text Views 110 110 4
PDF Downloads 121 121 4
EPUB Downloads 0 0 0

PubMed

Google Scholar